Reportlinker.com

Reportlinker.com

July 02, 2008 06:55 ET

Learn about the World Cardiovascular Catheters and Systems Market

LONDON, UNITED KINGDOM--(Marketwire - July 2, 2008) - Reportlinker.com announces that a new market research report related to the Cardiovascular diseases industry is available in its catalogue.

World Cardiovascular Catheters and Systems Market

http://www.reportlinker.com/p090641/World-Cardiovascular-Catheters-and-Systems-Market.html

This report analyzes the worldwide markets for Cardiovascular Catheters and Systems in Millions of US$. The major product segments analyzed are Diagnostic Catheters (Angiography Catheters, & Electrophysiology (EP) Mapping Catheters), and Therapeutic Catheters (Rapid-Exchange PTCA Balloon Catheters, Over-The-Wire PTCA Balloon Catheters, Electrophysiology (EP) Ablation Catheters, Atherectomy Catheters, Perfusion and Fixed-wire Catheters, & Guide Catheters). The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Latin America. Annual forecasts are provided for each region for the period of 2000 through 2015. The report profiles 81 companies including many key and niche players worldwide such as Abbott, Boston Scientific, C.R. Bard, Inc., Cardima, Inc., CryoCath Technologies Inc., Edwards Lifesciences Corporation, EP Medsystems, Johnson & Johnson, Cordis Corporation, Biosense Webster, Medtronic, Merit Medical Systems, Inc., St. Jude Medical, Endocardial Solutions, Inc., Teleflex Medical, and Terumo Medical Corporation. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.


CARDIOVASCULAR CATHETERS AND SYSTEMS MCP-3206 
A GLOBAL STRATEGIC BUSINESS REPORT 


CONTENTS 


I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS 
Study Reliability and Reporting Limitations I-1 
Disclaimers I-2 
Data Interpretation & Reporting Level I-2 
Quantitative Techniques & Analytics I-3 
Product Definitions and Scope of Study I-3 
A. Diagnostic Catheters I-4 
Angiography Catheters I-4 
Electrophysiology (EP) Mapping Catheters I-4 
B. Therapeutic Catheters I-4 
Rapid -Exchange PTCA Balloon Catheter I-4 
Over-The-Wire PTCA Balloon Catheter I-4 
Electrophysiology Ablation Catheters I-5 
Atherectomy Catheters I-5 
Perfusion and Fixed Balloon Catheters I-5 
Guide Catheters I-5 

II. EXECUTIVE SUMMARY 

1. Market Overview II-1 
Technological Advancements to Drive Growth II-1 
Worldwide Cardiovascular Catheters Market II-1 
Market Trends & Issues II-2 
Lack of Pharmacological Alternatives Boost Demand for 
Cardiovascular Catheters II-2 
Energy-Based Solutions Compete with Conventional 
Interventional Systems II-2 
Repeat Interventional Procedures Affected by the Advent of 
Drug-Eluting Stents II-2 
RF Catheter Ablation Gains Popularity II-3 
Molding Material and Technology II-3 
Diagnostic Catheters - Advance from the Workhorse 8 Fr II-3 
Smaller the Better II-3 
PTCA Catheters - Affected by Direct Stenting II-4 
Angioplasty - Under Price Pressure II-4 
Restenosis - The Unsolved Problem II-4 
New Pharmacological Therapies - Minimizing the Need for 
Interventional Procedures? II-4 

2. Competitive Scenario II-6 
Cardiovascular Catheters - Highly Concentrated Market II-6 
Table 1: Leading Players in Global Angioplasty / Angiography 
Catheter Market (2004 & 2005E): Percentage Breakdown of Value 
Sales for Boston Scientific Johnson & Johnson, Guidant, 
Medtronic, and Others (includes corresponding Graph/Chart) II-6 

Table 2: Leading Players in Global Guide Catheters Market 
(2004 & 2005): Percentage Breakdown of Value Sales for 
Johnson & Johnson, Boston Scientific, Guidant, Medtronic and 
Others (includes corresponding Graph/Chart) II-7 

Table 3: Leading Players in Global Electrophysiology (EP) 
Catheter (Mapping and Ablation) Market (2004 & 2005): 
Percentage Breakdown of Value Sales for Johnson & Johnson, 
St. Jude Medical, Boston Scientific,C.R.Bard and Others 
(includes corresponding Graph/Chart) II-7 
Balloon Catheters II-8 
Table 4: Leading Players in Global Balloon Catheter Market 
(2004 & 2005): Percentage Breakdown of Value Sales for Boston 
Scientific, Guidant, Medtronic, Johnson & Johnson and Others 
(includes corresponding Graph/Chart) II-8 

3. Catheterization - The Procedure II-9 
Historical Perspective II-9 
Cardiac Catheterization: Most Accurate of all Cardiac 
Diagnostic Examinations II-9 

4. Product Profile II-10 
Catheters II-10 
Designing of Specialized Catheters II-10 
Factors Determining Competitiveness II-10 
Preventing Infection II-10 
Catheter Related Infections II-10 
Flow and Sealing Capability II-10 
Safety II-11 
System Suitability and Comprehensiveness II-11 
Ease of Insertion II-11 
Maneuverability II-11 
Cardiovascular Catheters - Product Group/Segment Overview II-11 
A. Diagnostic Catheters II-12 
Angiography Catheters II-12 
Electrophysiology (EP) Mapping Catheters II-12 
Purpose II-12 
Scope of Electrophysiology Studies II-13 
Precaution II-13 
B. Therapeutic Catheters II-13 
Catheters Designed for Therapeutic Procedures II-13 
Angioplasty: Where is it Used? II-13 
Types of Angioplasty II-13 
Percutaneous Transluminal Coronary Angioplasty or PTCA II-14 
PTCA Catheters II-14 
Types of Balloon Catheters II-14 
Rapid -Exchange PTCA Balloon Catheter II-14 
Over-The-Wire PTCA Balloon Catheter II-15 
Electrophysiology Ablation Catheters II-15 
Atherectomy Catheters II-16 
Perfusion and Fixed Balloon Catheters II-16 
Guide Catheters II-16 

5. An Overview of The CVD Market II-17 
Heart - Historic Facts and Figures II-17 
Table 5: Number of Deaths from Circulatory Disorders 
Worldwide by Region (2002) (in '000) (includes Corresponding 
Graph/Chart) II-17 
Interventional Cardiology II-17 
PTCRA - The procedure II-18 
Interventional Cardiology Market in the US & Europe - A 
Comparison II-18 
Radiation Therapy (Brachytherapy) II-19 
An Insight into Cardio Vascular Diseases II-19 
Coronary Artery Disease (CAD) II-19 
Definition II-19 
Causes and Symptoms II-19 
Major Risk Factors II-20 
Non-Controllable Risk Factors II-20 
Heredity II-20 
Sex II-20 
Age II-20 
Controllable Risk Factors II-20 
Treatment II-20 
Angina Pectoris II-21 
Arrhythmias II-21 
Atrial Fibrillation - A Common Arrhythmia II-21 
More in Women II-22 
Stroke II-22 
Congestive Heart Failure II-22 
Key Terms (For Reference) II-22 
Angina II-22 
Aneurysms II-23 
Angiography II-23 
Angioplasty II-23 
Aortic Valve II-23 
Atherosclerosis II-23 
Bradycardia II-23 
Catheter II-23 
Coronary Arteries II-23 
Echocardiogram II-23 
Electrocardiogram II-23 
Electrophysiology (EP) study II-23 
Pacemaker II-24 
Plaque II-24 
HDL Cholesterol II-24 
LDL Cholesterol II-24 
Stenosis II-24 
Stroke II-24 
Tachycardia II-24 

6. Technological Developments II-25 
US-Based Inventors Granted Patent for Perfusion Balloon 
Angioplasty Catheter II-25 
California Scientists Create Intravascular Balloon Catheters 
for Angioplasty Procedures II-25 
Minnesota Scientists Develop New Ablation Catheter II-25 
American Inventor Devises Drug Delivery Balloon Catheter II-25 
US-Based Inventors Create Atherectomy Catheter II-25 
US-Based Inventors Develop Atherectomy Device for Treatment of 
Occlusions II-26 
US-Based Inventor Creates New Ablation Catheter System II-26 
Japanese Inventor Creates RF Thermal Balloon Catheter II-26 

7. Product Innovations/Intorductions II-27 
Stereotaxis Obtains FDA Approval for 8mm Magnetic Ablation 
Catheter II-27 
ClearStream Gains FDA Approval for PTA Angioplasty Balloon 
Catheters II-27 
AngioSculpt(R) Gains Japanese Approval for AngioSculpt(R) Catheter II-27 
Cordis Introduces Fire Star Rx and Dura Star Rx Catheters II-27 
Cordis Introduces AVIATOR(TM) Catheter II-28 
FlowCardia Introduces CROSSER Catheter Product Line II-28 
Medtronic's Sprinter(R) Catheter Gains CE Mark Approval II-28 
St. Jude Gains CE Mark & FDA Approvals for Therapy(TM) Cool Path(TM) 
Catheter II-28 
FDA Clears Venture(TM) Catheter Use with Rapid Exchange Delivery 
Platform II-29 
Eurocor Unveils DIOR Catheter in Germany II-29 
FDA Approves InnerChange Micro-Introducer Catheter II-29 
Stereotaxis Gains EU Approval Magnetic Irrigated Ablation 
Catheter II-29 
Atrium Medical Obtains CE Mark for ClearWay(TM) RX Catheter II-29 
Lumen Gains FDA Approval for Large Sized Xtract(TM) Catheters II-30 
Opto Circuits Achieves CE Mark Approval for its Catheter II-30 
FDA Approves Abiomed's Impella 5.0 Catheter-Based Circulatory 
Support Systems II-30 
Medical Ventures Gains CE Mark Approval for Metricath Gemini(R) 
Balloon-Catheter II-31 
St. Jude Receives Regulatory Approval for its Safire Ablation 
& Inquiry Optima Plus Catheters II-31 
Boston Scientific Introduces Sterling(TM) Monorail(R) Balloon 
Dilatation Catheter II-31 
St. Jude Receives Approval to Market EnSite(R) System in Japan II-31 
Merit Medical's Impress Diagnostic Catheter Gains CE Mark & 
FDA Approvals II-31 
Medtronic Gains FDA Approval for Export(R) XT spiration Catheter II-32 
Medtronic Obtains CE Mark Approval to Market Melody(TM) and 
Ensemble(TM) System II-32 
Boston Scientific Gains FDA Approval for its Rio(TM) Aspiration 
Catheter II-32 
Possis Introduces AngioJet(R) Spiroflex(R)Rheolytic Thrombectomy 
Catheter II-32 
Boston Scientific Launches Chilli II Cooled Ablation Catheter II-33 
Terumo Introduces PTCA Catheter with the Smallest Diameter II-33 
Japan Lifeline Introduces OTTIMO ROSSO Balloon atheter for 
PTCA Procedures II-33 
FDA Clears St. Jude's Therapy(TM) EP & IBI-1500T6 Cardiac 
Ablation Generator Catheters II-33 
Terumo Introduces Heartrail II PTCA Guiding Catheter II-33 
FDA Grants Approval to Alliance for Reprocessing AcuNav(TM) 
Ultrasound Catheter II-34 
Cook Introduces New ATB(R) PTA Dilatation Catheter II-34 
St. Jude Unveils New Venture(TM) Wire Control Catheter Across the 
United States II-34 
Possis Medical Adds Two New Catheters to its AngioJet(R) 
Rheolytic(TM) Thrombectomy Line II-34 
Cook Introduces CODA for Endovascular Market II-34 
Spectranetics Develops Laser Catheter for Peripheral Vascular 
Disease II-35 
Medrad Inc Introduces Avanta(TM) Fluid Management Injection 
System and Vanguard Dx(TM) Angiographic Catheter II-35 
Medtronic Releases Medtronic Attain Select 6238 TEL Guide 
Catheter II-35 
AngioScore Receives CE Mark Approval for its AngioSculpt 
Scoring Balloon Catheter II-35 
Spectranetics Introduces New Catheters II-36 
Guidant Corporation Unveils VOYAGER(TM) Coronary Dilatation Catheter II-36 
Medtronic Introduces Two New Catheters II-36 

8. Recent Industry Activity II-37 
Micrus Enters into Agreement with Genesis II-37 
Teleflex Acquires Arrow International II-37 
FoxHollow Merges with ev3 II-37 
J&J Bags Marketing Rights for Topspin's Catheter II-38 
Cordis to Market ClearStream Technologies' Catheters II-38 
Relisys to Establish Catheter Production Facility in India II-38 
Boston Scientific Acquires Guidant II-38 
Abbott Acquires Guidant's Vascular Business II-39 
Cordis in Distribution Agreement with Brivant II-39 
Cordis Enters into Definitive Agreement to Distribute 
ClearStream's PTCA Balloon Catheter II-39 
St. Jude and GE Healthcare Collaborate to Develop Advanced 
Technologies for Cardiac Procedures II-40 
Bard Acquires Venetec International II-40 
Koninklijke Philips Takes Over Witt Biomedical II-40 
FoxHollow Enters into Definitive Agreement to Acquire Kerberos II-40 
Biosense Recieves Expanded Indication for NAVISTAR(R) 
THERMOCOOLO Catheter for Treatment of Ventricular Tachycardia II-40 
Hansen Medical Completes Clinical Trial for Sensei Robotic 
Catheter System II-40 
Biosense and Siemens Enter into Strategic Alliance Involving 
Catheters II-41 
Recom Inks MOU with TZ Medical to Develop Cardiac Catheters II-41 
Cordis Takes Over LuMend II-41 
Hansen Medical Enters into Cross-Licensing Agreement with 
Intuitive Surgical II-42 
Hansen Medical Acquires Intellectual Assets of endoVia Medical II-42 
Micrus Takes Over VascularFX II-42 
St. Jude Medical Acquires Endocardial Solutions II-42 
St. Jude Medical Acquires Velocimed II-42 
FlowCardia Bags European Approval for Crosser Catheter II-43 
AVI BioPharma Regains Full Control on Resten-NG Antisense Therapy II-43 
Boston Scientific Acquires Precision Vascular Systems II-43 
Edwards Lifesciences Acquires PVT II-43 
St. Jude Medical Acquires IBI II-43 
St. Jude Medical Takes Over Epicor Medical II-44 
Merit Medical Systems Inks an Agreement with Novation II-44 
Rochester Medical Enters into a Supply Agreement with Hollister II-44 
CardioTech International Enters into a Licensing Agreement 
with BAS II-44 
CryoCor's Model 1200 Cardiac Catheter Series Receives FDA 
Clearance II-44 
CryoCath's Freezor MAX Catheter Device Receives FDA Clearance II-44 
LubriLAST(TM)-coated Catheters Receives MOHLW Clearance II-45 
Abbott Laboratories Acquires Assets of JOMED II-45 
JOMED Sells IVUS and Functional Management Business to Volcano 
Therapeutics II-45 
Boston Scientific in Alliance with Corautus Genetics II-45 
Mogul Obtains FDA Approval for Diagnostic Catheters II-45 

9. Focus on Select Global Players II-46 
Abbott Laboratories (USA) II-46 
Boston Scientific (USA) II-46 
C.R. Bard, Inc. (USA) II-47 
Cardima, Inc. (USA) II-47 
CryoCath Technologies Inc. (Canada) II-47 
Edwards Lifesciences Corporation (USA) II-48 
EP Medsystems (USA) II-48 
Johnson & Johnson (USA) II-48 
Cordis Corporation (USA) II-49 
Biosense Webster (USA) II-49 
Medtronic (USA) II-50 
Merit Medical Systems, Inc. (USA) II-50 
St. Jude Medical (USA) II-51 
Endocardial Solutions, Inc. (USA) II-51 
Teleflex Medical (USA) II-52 
Terumo Medical Corporation (Japan) II-52 

10. Global Market Perspective II-53 
Table 6: World Recent Past, Current & Future Analysis for 
Cardiovascular Catheters by Geographic Region - USA, Canada, 
Japan, Europe, Asia-Pacific (excluding Japan), and Latin 
American Markets Independently Analyzed with Annual Sales 
Figures in US$ Million for Years 2000 through 2010 (includes 
corresponding Graph/Chart) II-53 

Table 7: World Long-term Projections for Cardiovascular 
Catheters by Geographic Region - USA, Canada, Japan, Europe, 
Asia-Pacific (excluding Japan), and Latin American Markets 
Independently Analyzed with Annual Sales Figures in US$ 
Million for Years 2011 through 2015 (includes corresponding 
Graph/Chart) II-54 

Table 8: World 10-Year Perspective for Cardiovascular 
Catheters by Geographic Region - Percentage Breakdown of 
Dollar Sales for USA, Canada, Japan, Europe, Asia-Pacific 
(excluding Japan), and Latin American Markets for Years 2003, 
2008 & 2012 (includes corresponding Graph/Chart) II-55 

Table 9: World Recent Past, Current & Future Analysis for 
Diagnostic Catheters by Geographic Region - USA, Canada, 
Japan, Europe, Asia-Pacific (excluding Japan), and Latin 
American Markets Independently Analyzed with Annual Sales 
Figures in US$ Million for Years 2000 through 2010 
(includescorresponding Graph/Chart) II-56 

Table 10: World Long-term Projections for Diagnostic Catheters 
by Geographic Region - USA, Canada, Japan, Europe, 
Asia-Pacific (excluding Japan), and Latin American Markets 
Independently Analyzed with Annual Sales Figures in US$ 
Million for Years 2011 through 2015 (includes corresponding 
Graph/Chart) II-57 

Table 11: World Recent Past, Current & Future Analysis for 
Diagnostic Catheters by Product Segment - Angiography 
Catheters and EP Mapping Catheters Markets Independently 
Analyzed with Annual Sales Figures in US$ Million for Years 
2000 through 2010 (includes corresponding Graph/Chart) II-58 

Table 12: World Long-term Projections for Diagnostic Catheters 
by Product Segment - Angiography Catheters & EP Mapping 
Catheters Markets Independently Analyzed with Annual Sales 
Figures in US$ Million for Years 2011 through 2015 (includes 
corresponding Graph/Chart) II-58 

Table 13: World 10-Year Perspective for Diagnostic Catheters 
by Geographic Region - Percentage Breakdown of Dollar Sales 
for USA, Canada, Japan, Europe, Asia-Pacific (excluding 
Japan), and Latin American Markets for Years 2003, 2008 & 2012 
(includes corresponding Graph/Chart) II-59 

Table 14: World 10-Year Perspective for DiagnosticcCatheters 
by Product Segment - Percentage Breakdowncof Dollar Sales for 
Angiography Catheters and EP Mapping Catheters Markets for 
Years 2003, 2008 & 2012 II-59 

Table 15: World Recent Past, Current & Future Analysis for 
Angiography Catheters by Geographic Region - USA, Canada, 
Japan, Europe, Asia-Pacific (excluding Japan), and Latin 
American Markets Independently Analyzedcwith Annual Sales 
Figures in US$ Million forcYears 2000 through 2010 (includes 
corresponding Graph/Chart) II-60 

Table 16: World Long-term Projections for Angiography 
Catheters by Geographic Region - USA, Canada, Japan, Europe, 
Asia-Pacific (excluding Japan), and Latin American Markets 
Independently Analyzed with Annual Sales Figures in US$ 
Million for Years 2011 through 2015 (includes corresponding 
Graph/Chart) II-61 

Table 17: World 10-Year Perspective for Angiography Catheters 
by Geographic Region - Percentage Breakdown of Dollar Sales 
for USA, Canada, Japan, Europe,Asia-Pacific (excluding 
Japan), and Latin American Markets for Years 2003, 2008 & 
2012 (includes corresponding Graph/Chart) II-62 

Table 18: World Recent Past, Current & Future Analysis for EP 
Mapping Catheters by Geographic Region - USA, Canada, Japan, 
Europe, Asia-Pacific (excluding Japan), and Latin American 
Markets Independently Analyzed with Annual Sales Figures in 
US$ Million for Years 2000 through 2010 (includes 
corresponding Graph/Chart) II-63 

Table 19: World Long-term Projections for EP Mapping Catheters 
by Geographic Region - USA, Canada, Japan, Europe, 
Asia-Pacific (excluding Japan), and Latin American Markets 
Independently Analyzed with Annual Sales Figures in US$ 
Million for Years 2011 through 2015 (includes corresponding 
Graph/Chart) II-64 

Table 20: World 10-Year Perspective for EP Mapping Catheters 
by Geographic Region - Percentage Breakdown of Dollar Sales 
for USA, Canada, Japan, Europe, Asia-Pacific (excluding 
Japan), and Latin American Markets for Years 2003, 2008 & 2012 
(includes corresponding Graph/Chart) II-65 

Table 21: World Recent Past, Current & Future Analysis for 
Therapeutic Catheters by Geographic Region - USA, Canada, 
Japan, Europe, Asia-Pacific (excluding Japan), and Latin 
American Markets Independently Analyzed with Annual Sales 
Figures in US$ Million for Years 2000 through 2010 (includes 
corresponding Graph/Chart) II-66 

Table 22: World Long-term Projections for Therapeutic 
Catheters by Geographic Region - USA, Canada, Japan, Europe, 
Asia-Pacific (excluding Japan), and Latin American Markets 
Independently Analyzed with Annual Sales Figures in US$ 
Million for Years 2011 through 2015 (includes corresponding 
Graph/Chart) II-67 

Table 23: World Recent Past, Current & Future Analysis for 
Therapeutic Catheters by Product Segment - Rapid-Exchange PTCA 
Balloon Catheters, Over-The-Wire PTCA Balloon Catheters, EP 
Ablation Catheters, Atherectomy Catheters, Perfusion and Fixed 
Balloon, and Guide Catheters Markets Independently Analyzed 
with Annual Sales Figures in US$ Million for Years 2000 
through 2010 (includes corresponding Graph/Chart) II-68 

Table 24: World Long-term Projections for Therapeutic 
Catheters by Product Segment - Rapid-Exchange PTCA Balloon 
Catheters, Over-The-Wire PTCA Balloon Catheters, EP Ablation 
Catheters, Atherectomy Catheters, Perfusion and Fixed Balloon, 
and Guide Catheters Markets Independently Analyzed with Annual 
Sales Figures in US$ Million for Years 2011 through 2015 
(includes corresponding Graph/Chart) II-68 

Table 25: World 10-Year Perspective for Therapeutic Catheters 
by Geographic Region - Percentage Breakdown of Dollar Sales 
for USA, Canada, Japan, Europe, Asia-Pacific (excluding 
Japan), and Latin American Markets for Years 2003, 2008 & 
2012 (includes corresponding Graph/Chart) II-69 

Table 26: World 10-Year Perspective for Therapeutic Catheters 
by Product Segment - Percentage Breakdown of Dollar Sales for 
Rapid-Exchange PTCA Balloon Catheters, Over-The-Wire PTCA 
Balloon Catheters, EP Ablation Catheters, Atherectomy 
Catheters, Perfusion and Fixed Balloon, and Guide Catheters 
Markets for Years 2003, 2008 & 2012 (includes corresponding 
Graph/Chart) II-70 

Table 27: World Recent Past, Current & Future Analysis for 
Rapid-Exchange PTCA Balloon Catheters by Geographic Region - 
USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), 
and Latin American Markets Independently Analyzed with Annual 
Sales Figures in US$ Million for Years 2000 through 2010 
(includes corresponding Graph/Chart) II-71 

Table 28: World Long-term Projections for Rapid-Exchange PTCA 
Balloon Catheters by Geographic Region - USA, Canada, Japan, 
Europe, Asia-Pacific (excluding Japan), and Latin American 
Markets Independently Analyzed with Annual Sales Figures in 
US$ Million for Years 2011 through 2015 (includes 
corresponding Graph/Chart) II-72 

Table 29: World 10-Year Perspective for Rapid-Exchange PTCA 
Balloon Catheters by Geographic Region - Percentage Breakdown 
of Dollar Sales for USA, Canada, Japan, Europe, Asia-Pacific 
(excluding Japan), and Latin American Markets for Years 2003, 
2008 & 2012 (includes corresponding Graph/Chart) II-73 

Table 30: World Recent Past, Current & Future Analysis for 
Over-the-Wire PTCA Balloon Catheters by Geographic Region - 
USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), 
and Latin American Markets Independently Analyzed with Annual 
Sales Figures in US$ Million for Years 2000 through 2010 
(includes corresponding Graph/Chart) II-74 

Table 31: World Long-term Projections for Over-the-Wire PTCA 
Balloon Catheters by Geographic Region - USA, Canada, Japan, 
Europe, Asia-Pacific (excluding Japan), and Latin American 
Markets Independently Analyzed with Annual Sales Figures in 
US$ Million for Years 2011 through 2015 (includes 
corresponding Graph/Chart) II-75 

Table 32: World 10-Year Perspective for Over-the-Wire PTCA 
Balloon Catheters by Geographic Region - Percentage Breakdown 
of Dollar Sales for USA, Canada, Japan, Europe, Asia-Pacific 
(excluding Japan), and Latin American Markets for Years 2003, 
2008 & 2012 (includes corresponding Graph/Chart) II-76 

Table 33: World Recent Past, Current & Future Analysis for EP 
Ablation Catheters by Geographic Region - USA, Canada, Japan, 
Europe, Asia-Pacific (excluding Japan), and Latin American 
Markets Independently Analyzed with Annual Sales Figures in 
US$ Million for Years 2000 through 2010 (includes 
corresponding Graph/Chart) II-77 

Table 34: World Long-term Projections for EP Ablation 
Catheters by Geographic Region - USA, Canada, Japan, Europe, 
Asia-Pacific (excluding Japan), and Latin American Markets 
Independently Analyzed with Annual Sales Figures in US$ 
Million for Years 2011 through 2015 (includes corresponding 
Graph/Chart) II-78 

Table 35: World 10-Year Perspective for EP Ablation Catheters 
by Geographic Region - Percentage Breakdown of Dollar Sales 
for USA, Canada, Japan, Europe, Asia-Pacific (excluding 
Japan), and Latin American Markets for Years 2003, 2008 & 2012 
(includes corresponding Graph/Chart) II-79 

Table 36: World Recent Past, Current & Future Analysis for 
Atherectomy Catheters by Geographic Region - USA, Canada, 
Japan, Europe, Asia-Pacific (excluding Japan), and Latin 
American Markets Independently Analyzed with Annual Sales 
Figures in US$ Million for Years 2000 through 2010 (includes 
corresponding Graph/Chart) II-80 

Table 37: World Long-term Projections for Atherectomy 
Catheters by Geographic Region - USA, Canada, Japan, Europe, 
Asia-Pacific (excluding Japan), and Latin American Markets 
Independently Analyzed with Annual Sales Figures in US$ 
Million for Years 2011 through 2015 (includes corresponding 
Graph/Chart) II-81 

Table 38: World 10-Year Perspective for Atherectomy Catheters 
by Geographic Region - Percentage Breakdown of Dollar Sales 
for USA, Canada, Japan, Europe, Asia-Pacific (excluding 
Japan), and Latin American Markets for Years 2003, 2008 & 2012 
(includes corresponding Graph/Chart) II-82 

Table 39: World Recent Past, Current & Future Analysis for 
Perfusion and Fixed Balloon Catheters by Geographic Region - 
USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), 
and Latin American Markets Independently Analyzed with Annual 
Sales Figures in US$ Million for Years 2000 through 2010 
(includes corresponding Graph/Chart) II-83 

Table 40: World Long-term Projections for Perfusion and Fixed 
Balloon Catheters by Geographic Region - USA, Canada, Japan, 
Europe, Asia-Pacific (excluding Japan), and Latin American 
Markets Independently Analyzed with Annual Sales Figures in 
US$ Million for Years 2011 through 2015 (includes 
corresponding Graph/Chart) II-84 

Table 41: World 10-Year Perspective for Perfusion and Fixed 
Balloon Catheters by Geographic Region - Percentage Breakdown 
of Dollar Sales for USA, Canada, Japan, Europe, Asia-Pacific 
(excluding Japan), and Latin American Markets for Years 2003, 
2008 & 2012 (includes corresponding Graph/Chart) II-85 

Table 42: World Recent Past, Current & Future Analysis for 
Guide Catheters by Geographic Region - USA, Canada, Japan, 
Europe, Asia-Pacific (excluding Japan), and Latin American 
Markets Independently Analyzed with Annual Sales Figures in 
US$ Million for Years 2000 through 2010 (includes 
corresponding Graph/Chart) II-86 

Table 43: World Long-term Projections for Guide Catheters by 
Geographic Region - USA, Canada, Japan, Europe, Asia-Pacific 
(excluding Japan), and Latin American Markets Independently 
Analyzed with Annual Sales Figures in US$ Million for Years 
2011 through 2015 (includes corresponding Graph/Chart) II-87 

Table 44: World 10-Year Perspective for Guide Catheters by 
Geographic Region - Percentage Breakdown of Dollar Sales for 
USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), 
and Latin American Markets for Years 2003, 2008 & 2012 
(includes corresponding Graph/Chart) II-88 

III. MARKET 

1. The United States III-1 
A.Market Analysis III-1 
Current & Future Analysis III-1 
Cardiovascular Catheters Market III-1 
Competition III-1 
Table 45: Leading Players in the US Cardiovascular 
Catheters Market (2005): Percentage Breakdown of Value 
Sales for Boston Scientific, Cordis (J&J), Guidant 
Corporation, Medtronic, and Others (includes corresponding 
Graph/Chart) III-2 
Arrhythmia Management Products III-3 
Cardiovascular Disease in the US - An Insight III-3 
Table 46: Prevalence of Cardiovascular Disease in the US: 
2004 (Includes Corresponding Graph/Chart) III-4 
Market Trends and Issues III-4 
Rising Obesity Rates & Numbers Lead to Increased Number of 
Interventional Cardiac Procedures III-4 
Reimbursements - A Major Issue Affecting Growth in 
Cardiovascular Devices Market III-4 
Need for Advanced Cardiovascular Devices at Competitive Prices III-4 
Inadequate Clinical Evidence Deters Surgeons from Adopting 
New Catheters III-5 
Increasing Demand for Atherectomy & Thrombectomy Products III-5 
Need for Improvement in Hypotube Design III-5 
Reimbursement Rates in the US III-5 
Table 47: Common Physician Payments for Percutaneous 
Coronary Interventions III-5 

Table 48: Common Outpatient Ambulatory Procedure 
classifications (APCs) for Percutaneous Coronary 
Interventions III-6 

Table 49: Medicare Physician Professional Payment III-6 
Table 50: Payment for Carotid Artery Stenting III-6 
Payment for Peripheral Interventions III-6 
Table 51: Hospital In-patient Payment III-6 
Table 52: Hospital Outpatient - Based on APCClassification III-6 
Table 53: Physician Professional Payment - Based on CPT(R) 
Code III-7 
Table 54: Peripheral Stent / Shunt Placement, Percutaneous III-7 
Table 55: Catheter Placement III-7 
Table 56: Diagnostic Angiography, Radiological S&I III-8 
Table 57: Procedural Radiological S&I III-8 
Product Launches/ Approvals/Patents III-9 
Strategic Developments III-16 
Key Players III-24 
Abbott Laboratories III-24 
Boston Scientific Corporation III-24 
C.R. Bard, Inc. III-25 
Cardima, Inc. III-25 
Cardiofocus, Inc. III-26 
Edwards Lifesciences Corporation III-26 
EP Medsystems III-27 
Johnson & Johnson III-27 
Cordis Corporation III-27 
Biosense Webster III-28 
Medtronic, Inc. III-28 
Merit Medical Systems, Inc. III-29 
Spectranetics Corporation III-29 
St. Jude Medical III-29 
Endocardial Solutions, Inc. III-30 
Teleflex Medical III-30 
B.Market Analytics III-32 
Table 58: US Recent Past, Current & Future Analysis for 
Cardiovascular Catheters by Product Group/Segment - 
Diagnostic Catheters (Angiography Catheters and EP Mapping 
Catheters) and Therapeutic Catheters (Rapid-Exchange PTCA 
Balloon Catheters, Over-The-Wire PTCA Balloon Catheters, EP 
Ablation Catheters, Atherectomy Catheters, Perfusion and 
Fixed Balloon, and Guide Catheters) Markets Independently 
Analyzed with Annual Sales Figures in US$ Million for Years 
2000 through 2010 (includes corresponding Graph/Chart) III-32 

Table 59: US Long-term Projections for Cardiovascular 
Catheters by Product Group/Segment - Diagnostic Catheters 
(Angiography Catheters and EP Mapping Catheters) and 
Therapeutic Catheters (Rapid-Exchange PTCA Balloon 
Catheters, Over-The-Wire PTCA Balloon Catheters, EP Ablation 
Catheters, Atherectomy Catheters, Perfusion and Fixed 
Balloon, and Guide Catheters) Markets Independently Analyzed 
with Annual Sales Figures in US$ Million for Years 2011 
through 2015 (includes corresponding Graph/Chart) III-33 

Table 60: US 10-Year Perspective for Cardiovascular 
Catheters by Product Group/Segment - Percentage Breakdown of 
Dollar Sales for Diagnostic Catheters (Angiography Catheters 
and EP Mapping Catheters) and Therapeutic Catheters 
(Rapid-Exchange PTCA Balloon Catheters, Over-The-Wire PTCA 
Balloon Catheters, EP Ablation Catheters, Atherectomy 
Catheters, Perfusion and Fixed Balloon, and Guide Catheters) 
Markets for Years 2003, 2008 & 2012 (includes corresponding 
Graph/Chart) III-34 

2. Canada III-35 
A.Market Analysis III-35 
Current & Future Analysis III-35 
Key Player III-35 
CryoCath Technologies, Inc. III-35 
B.Market Analytics III-36 
Table 61: Canadian Recent Past, Current & Future Analysis 
for Cardiovascular Catheters by Product Group/Segment - 
Diagnostic Catheters (Angiography Catheters and EP Mapping 
Catheters) and Therapeutic Catheters (Rapid-Exchange PTCA 
Balloon Catheters, Over-The-Wire PTCA Balloon Catheters, EP 
Ablation Catheters, Atherectomy Catheters, Perfusion & Fixed 
Balloon, and Guide Catheters) Markets Independently Analyzed 
with Annual Sales Figures in US$ Million for Years 2000 
through 2010 (includes corresponding Graph/Chart) III-36 

Table 62: Canadian Long-term Projections for Cardiovascular 
Catheters by Product Group/Segment - Diagnostic Catheters 
(Angiography Catheters and EP Mapping Catheters) and 
Therapeutic Catheters (Rapid-Exchange PTCA Balloon 
Catheters, Over-The-Wire PTCA Balloon Catheters, EP Ablation 
Catheters, Atherectomy Catheters, Perfusion and Fixed 
Balloon,& Guide Catheters) Markets Independently Analyzed 
with Annual Sales Figures in US$ Million for Years 2011 
through 2015 (includes corresponding Graph/Chart) III-37 

Table 63: Canadian 10-Year Perspective for Cardiovascular 
Catheters by Product Group/Segment - Percentage Breakdown of 
Dollar Sales for Diagnostic Catheters (Angiography Catheters 
and EP Mapping Catheters) and Therapeutic Catheters 
(Rapid-Exchange PTCA Balloon Catheters, Over-The-Wire PTCA 
Balloon Catheters, EP Ablation Catheters, Atherectomy 
Catheters, Perfusion and Fixed Balloon, and Guide Catheters) 
Markets for Years 2003, 2008 & 2012 (includes corresponding 
Graph/Chart) III-38 

3. Japan III-39 
A.Market Analysis III-39 
Current & Future Analysis III-39 
PTCA Catheter Market III-39 
Product Launches/Developments III-39 
Key Players III-41 
Japan Lifeline Co., Ltd. III-41 
Terumo Medical Corporation III-41 
Tokai Medical Products Co., Ltd. III-41 
B.Market Analytics III-42 
Table 64: Japanese Recent Past, Current & Future Analysis 
for Cardiovascular Catheters by Product Group/Segment - 
Diagnostic Catheters (Angiography Catheters and EP Mapping 
Catheters) and Therapeutic Catheters (Rapid-Exchange PTCA 
Balloon Catheters,Over-The-Wire PTCA Balloon Catheters, EP 
Ablation Catheters, Atherectomy Catheters, Perfusion and 
Fixed Balloon, and Guide Catheters) Markets Independently 
Analyzed with Annual Sales Figures in US$ Million for Years 
2000 through 2010 (includes corresponding Graph/Chart) III-42 

Table 65: Japanese Long-term Projections for Cardiovascular 
Catheters by Product Group/Segment - Diagnostic Catheters 
(Angiography Catheters and EP Mapping Catheters) and 
Therapeutic Catheters (Rapid-Exchange PTCA Balloon 
Catheters, Over-The-Wire PTCA Balloon Catheters, EP 
Ablation Catheters, Atherectomy Catheters, Perfusion & 
Fixed Balloon, and Guide Catheters) Markets Independently 
Analyzed with Annual Sales Figures in US$ Million forYears 
2011 through 2015 (includes corresponding Graph/Chart) III-43 

Table 66: Japanese 10-Year Perspective for Cardiovascular 
Catheters by Product Group/Segment - Percentage Breakdown of 
Dollar Sales for Diagnostic Catheters (Angiography 
Catheters and EP Mapping Catheters) and Therapeutic 
Catheters (Rapid-Exchange PTCA Balloon Catheters, 
Over-The-Wire PTCA Balloon Catheters, EP Ablation Catheters, 
Atherectomy Catheters, Perfusion and Fixed Balloon, and 
Guide Catheters) Markets for Years 2003, 2008 & 2012 
(includes corresponding Graph/Chart) III-44 

4. Europe III-45 
A.Market Analysis III-45 
Current & Future Analysis III-45 
European Union Cardiovascular Diseases Fact Sheet III-45 
Angioplasty Products Market III-46 
Trends Observed in Various Countries III-46 
Product Launches/Developments III-46 
Strategic Corporate Developments III-48 
B.Market Analytics III-50 
Table 67: European Recent Past, Current & Future Analysis 
for Cardiovascular Catheters by Geographic Region - France, 
Germany, Italy, UK, and Rest of Europe Markets 
Independently Analyzed with Annual Sales Figures in US$ 
Million for Years 2000 through 2010 (includes 
corresponding Graph/Chart) III-50 

Table 68: European Long-term Projections for Cardiovascular 
Catheters by Geographic Region - France, Germany, Italy, 
UK, and Rest of Europe Markets Independently Analyzed with 
Annual Sales Figures in US$ Million for Years 2011 through 
2015 (includes corresponding Graph/Chart) III-50 

Table 69: European Recent Past, Current & Future Analysis 
for Cardiovascular Catheters by Product Group/Segment - 
Diagnostic Catheters (Angiography Catheters and EP Mapping 
Catheters) and Therapeutic Catheters (Rapid-Exchange PTCA 
Balloon Catheters, Over-The-Wire PTCA Balloon Catheters, EP 
Ablation Catheters, Atherectomy Catheters, Perfusion and 
Fixed Balloon, and Guide Catheters) Markets Independently 
Analyzed with Annual Sales Figures in US$ Million for Years 
2000 through 2010 (includes corresponding Graph/Chart) III-51 

Table 70: Canadian Long-term Projections for Cardiovascular 
Catheters by Product Group/Segment - Diagnostic Catheters 
(Angiography Catheters and EP Mapping Catheters) and 
Therapeutic Catheters (Rapid-Exchange PTCA Balloon 
Catheters, Over-The-Wire PTCA Balloon Catheters, EP Ablation 
Catheters, Atherectomy Catheters, Perfusion & Fixed Balloon, 
and Guide Catheters) Markets Independently Analyzed with 
Annual Sales Figures in US$ Millionfor Years 2011 through 
2015 (includescorresponding Graph/Chart) III-52 

Table 71: European 10-Year Perspective for Cardiovascular 
Catheters by Geographic Region - Percentage Breakdown of 
Dollar Sales for France, Germany, Italy, UK, and Rest of 
Europe Markets for Years 2003, 2008 and 2012 (includes 
corresponding Graph/Chart) III-53 

Table 72: European 10-Year Perspective for Cardiovascular 
Catheters by Product Group/Segment - Percentage Breakdown of 
Dollar Sales for Diagnostic Catheters (Angiography Catheters 
and EP Mapping Catheters) and Therapeutic Catheters 
(Rapid-Exchange PTCA Balloon Catheters, Over-The-Wire PTCA 
Balloon Catheters, EP Ablation Catheters, Atherectomy 
Catheters, Perfusion and Fixed Balloon, and Guide Catheters) 
Markets for Years 2003, 2008 and 2012 (includes 
corresponding Graph/Chart) III-54 

4a. France III-55 
A.Market Analysis III-55 
Current & Future Analysis III-55 
EP Catheters Market III-55 
B.Market Analytics III-56 
Table 73: French Recent Past, Current & Future Analysis for 
Cardiovascular Catheters by Product Group/Segment - 
Diagnostic Catheters (Angiography Catheters and EP Mapping 
Catheters) and Therapeutic Catheters (Rapid-Exchange PTCA 
Balloon Catheters, Over-The-Wire PTCA Balloon Catheters, EP 
Ablation Catheters, Atherectomy Catheters, Perfusion and 
Fixed Balloon, and Guide Catheters) Markets Independently 
Analyzed with Annual Sales Figures in US$ Million for Years 
2000 through 2010 (includes corresponding Graph/Chart) III-56 

Table 74: French Long-term Projections for Cardiovascular 
Catheters by Product Group/Segment - Diagnostic Catheters 
(Angiography Catheters and EP Mapping Catheters) and 
Therapeutic Catheters (Rapid-Exchange PTCA Balloon 
Catheters, Over-The-Wire PTCA Balloon Catheters, EP Ablation 
Catheters, Atherectomy Catheters, Perfusion and Fixed 
Balloon, and Guide Catheters) Markets Independently Analyzed 
with Annual Sales Figures in US$ Million for Years 2011 
through 2015 (includes corresponding Graph/Chart) III-57 

Table 75: French 10-Year Perspective for Cardiovascular 
Catheters by Product Group/Segment - Percentage Breakdown of 
Dollar Sales for Diagnostic Catheters (Angiography Catheters 
and EP Mapping Catheters) and Therapeutic Catheters 
(Rapid-Exchange PTCA Balloon Catheters, Over-The-Wire PTCA 
Balloon Catheters, EP Ablation Catheters, Atherectomy 
Catheters, Perfusion and Fixed Balloon, and Guide Catheters) 
Markets for Years 2003, 2008 & 2012 (includes corresponding 
Graph/Chart) III-58 

4b. Germany III-59 
A.Market Analysis III-59 
Current & Future Analysis III-59 
Electrophysiology Market Overview III-59 
Competitive Scenario III-59 
B.Market Analytics III-60 
Table 76: German Recent Past, Current & Future Analysis for 
Cardiovascular Catheters by Product Group/Segment - 
Diagnostic Catheters (Angiography Catheters and EP Mapping 
Catheters) and Therapeutic Catheters (Rapid-Exchange PTCA 
Balloon Catheters, Over-The-Wire PTCA Balloon Catheters, EP 
Ablation Catheters, Atherectomy Catheters, Perfusion and 
Fixed Balloon, and Guide Catheters) Markets Independently 
Analyzed withAnnual Sales Figures in US$ Million for Years 
2000 through 2010 (includes corresponding Graph/Chart) III-60 

Table 77: German Long-term Projections for Cardiovascular 
Catheters by Product Group/Segment - Diagnostic Catheters 
(Angiography Catheters and EP Mapping Catheters) and 
Therapeutic Catheters (Rapid-Exchange PTCA Balloon 
Catheters, Over-The-Wire PTCA Balloon Catheters, EP Ablation 
Catheters, Atherectomy Catheters, Perfusion and Fixed 
Balloon, and Guide Catheters) Markets Independently Analyzed 
with Annual Sales Figures in US$ Million for Years 2011 
through 2015 (includes corresponding Graph/Chart) III-61 

Table 78: German 10-Year Perspective for Cardiovascular 
Catheters by Product Group/Segment - Percentage Breakdown of 
Dollar Sales for Diagnostic Catheters (Angiography Catheters 
and EP Mapping Catheters) and Therapeutic Catheters 
(Rapid-Exchange PTCA Balloon Catheters, Over-The-Wire PTCA 
Balloon Catheters, EP Ablation Catheters, Atherectomy 
Catheters, Perfusion and Fixed Balloon, and Guide Catheters) 
Markets for Years 2003, 2008 & 2012 (includes corresponding 
Graph/Chart) III-62 

4c. Italy III-63 
A.Market Analysis III-63 
Current & Future Analysis III-63 
Electrophysiology Market Overview III-63 
B.Market Analytics III-64 
Table 79: Italian Recent Past, Current & Future Analysis for 
Cardiovascular Catheters by Product Group/Segment - 
Diagnostic Catheters (Angiography Catheters and EP Mapping 
Catheters) and Therapeutic Catheters (Rapid-Exchange PTCA 
Balloon Catheters, Over-The-Wire PTCA Balloon Catheters, EP 
Ablation Catheters, Atherectomy Catheters, Perfusion and 
Fixed Balloon, and Guide Catheters) Markets Independently 
Analyzed with Annual Sales Figures in US$ Million for Years 
2000 through 2010 (includes corresponding Graph/Chart) III-64 

Table 80: Italian Long-term Projections for Cardiovascular 
Catheters by Product Group/Segment - Diagnostic Catheters 
(Angiography Catheters and EP Mapping Catheters) and 
Therapeutic Catheters (Rapid-Exchange PTCA Balloon 
Catheters, Over-The-Wire PTCA Balloon Catheters, EP Ablation 
Catheters, Atherectomy Catheters, Perfusion and Fixed 
Balloon, and Guide Catheters) Markets Independently Analyzed 
with Annual Sales Figures in US$ Million for Years 2011 
through 2015 (includes corresponding Graph/Chart) III-65 

Table 81: Italian 10-Year Perspective for Cardiovascular 
Catheters by Product Group/Segment - Percentage Breakdown of 
Dollar Sales for Diagnostic Catheters (Angiography Catheters 
and EP Mapping Catheters) and Therapeutic Catheters 
(Rapid-Exchange PTCA Balloon Catheters, Over-The-Wire PTCA 
Balloon Catheters, EP Ablation Catheters, Atherectomy 
Catheters, Perfusion and Fixed Balloon, and Guide Catheters) 
Markets for Years 2003, 2008 & 2012 (includes corresponding 
Graph/Chart) III-66 

4d. The United Kingdom III-67 
A.Market Analysis III-67 
Current & Future Analysis III-67 
Healthcare Industry III-67 
UK Cardiovascular Diseases Fact Sheet III-67 
B.Market Analytics III-68 
Table 82: UK Recent Past, Current & Future Analysis for 
Cardiovascular Catheters by Product Group/Segment - 
Diagnostic Catheters (Angiography Catheters and EP Mapping 
Catheters) and Therapeutic Catheters (Rapid-Exchange PTCA 
Balloon Catheters, Over-The-Wire PTCA Balloon Catheters, EP 
Ablation Catheters, Atherectomy Catheters, Perfusion and 
Fixed Balloon, and Guide Catheters) Markets Independently 
Analyzed with Annual Sales Figures in US$ Million for Years 
2000 through 2010 (includes corresponding Graph/Chart) III-68 

Table 83: UK Long-term Projections for Cardiovascular 
Catheters by Product Group/Segment - Diagnostic Catheters 
(Angiography Catheters and EP Mapping Catheters) and 
Therapeutic Catheters (Rapid-Exchange PTCA Balloon 
Catheters, Over-The-Wire PTCA Balloon Catheters, EP Ablation 
Catheters, Atherectomy Catheters, Perfusion and Fixed 
Balloon, and Guide Catheters) Markets Independently Analyzed 
with Annual Sales Figures in US$ Million for Years 2011 
through 2015 (includes corresponding Graph/Chart) III-69 

Table 84: UK 10-Year Perspective for Cardiovascular 
Catheters by Product Group/Segment - Percentage Breakdown of 
Dollar Sales for Diagnostic Catheters (Angiography Catheters 
and EP Mapping Catheters) and Therapeutic Catheters 
(Rapid-Exchange PTCA Balloon Catheters, Over-The-Wire PTCA 
Balloon Catheters, EP Ablation Catheters, Atherectomy 
Catheters, Perfusion and Fixed Balloon, and Guide Catheters) 
Markets for Years 2003, 2008 & 2012 (includes corresponding 
Graph/Chart) III-70 

4e. Rest of Europe III-71 
A.Market Analysis III-71 
Current & Future Analysis III-71 
Spain III-71 
Electrophysiology Market III-71 
Outlook III-71 
B.Market Analytics III-72 
Table 85: Rest of Europe Recent Past, Current & Future 
Analysis for Cardiovascular Catheters by Product Group/ 
Segment - Diagnostic Catheters (Angiography Catheters and EP 
Mapping Catheters) and Therapeutic Catheters 
(Rapid-Exchange PTCA Balloon Catheters, Over-The-Wire PTCA 
Balloon Catheters, EP Ablation Catheters, Atherectomy 
Catheters, Perfusion and Fixed Balloon, and Guide Catheters) 
Markets Independently Analyzed with Annual Sales Figures in 
US$ Million for Years 2000 through 2010 (includes 
corresponding Graph/Chart) III-72 

Table 86: Rest of Europe Long-term Projections for 
Cardiovascular Catheters by Product Group/ Segment - 
Diagnostic Catheters (Angiography Catheters and EP Mapping 
Catheters) and Therapeutic Catheters (Rapid-Exchange PTCA 
Balloon Catheters, Over-The-Wire PTCA Balloon Catheters, EP less than b

To order this report:

World Cardiovascular Catheters and Systems Market

http://www.reportlinker.com/p090641/World-Cardiovascular-Catheters-and-Systems-Market.html

More market research reports here!

Contact Information